Celldex Therapeutics
Clinical trials sponsored by Celldex Therapeutics, explained in plain language.
-
New hope for chronic hives: Long-Term drug study launches
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of barzolvolimab for adults with chronic spontaneous urticaria (CSU), a condition causing frequent hives and itching. About 1,370 participants who finished earlier phase 3 trials will receive the drug and be monitored for…
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:13 UTC
-
New hope for cold hives and scratch-induced welts: phase 3 drug trial underway
Disease control Recruiting nowThis study tests an investigational drug called barzolvolimab in 240 adults who still get hives from cold temperatures or skin scratching despite taking antihistamines. Participants receive either the drug or a placebo to see if it can stop these reactions. The goal is to find a …
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:10 UTC
-
New asthma drug trial aims for safer symptom control
Symptom relief Recruiting nowThis early-stage study tests a single dose of an experimental drug called CDX-622 in 12 adults with mild to moderate asthma. The main goal is to check if the drug is safe and how the body processes it. Researchers will also measure changes in airway inflammation and blood cells l…
Phase: PHASE1 • Sponsor: Celldex Therapeutics • Aim: Symptom relief
Last updated May 20, 2026 11:53 UTC